A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso

NCT01635647 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

730

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: ChAd63 ME-TRAP and MVA ME-TRAP
BIOLOGICAL: Rabies vaccine

Sponsor

University of Oxford

Collaborators

[object Object]